In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $49.49, denoting a -0.2% change from the preceding trading day.

CRISPR Therapeutics' (NASDAQ: CRSP) stock may be down by 21% this year so far, but that doesn't mean you should write it off ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $49.59, marking a -0.56% move from the previous day.

The study finds that investors are selling and repurchasing nearly identical exchange-traded funds (ETFs), a group of stocks, ...

CRISPR Therapeutics' stock may seem boring due to slow FDA trial and rollout process, but it's a strong long-term investment.

Nairobi Governor Johson Sakaja has announced that 113,000 youth applied for the Climate Resilience Service Program (CRSP) ...

Hello, and welcome to The Kenya Times Weekly Roundup! This week has been a rollercoaster, filled with monumental ...

Crispr Therapeutics 40% share in Casgevy could result in revenue annual between $1.2 billion and $2.8 billion towards the end ...

Headlines,CRISPR Therapeutics,(NASDAQ:CRSP),has achieved a significant regulatory milestone with its gene-editing therapy, ...

Given all these factors, it seems reasonable to assume that Casgevy could grab at least a decent share, perhaps 20% of its ...

We recently compiled a list of the 10 Worst ARK Stocks To Buy According To Short Sellers. In this article, we are going to ...

Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth ...